{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:04:25Z","timestamp":1764072265434,"version":"3.45.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,10]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy caused by reduced activity of the von Willebrand factor-cleaving protease (ADAMTS13), which can be life-threatening. The patient reported in this case study also had concurrent Sj\u00f6gren syndrome and renal impairment, presenting multiple symptoms and posing a great challenge in treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 25-year-old woman in the postpartum period visited the hospital due to indifference in consciousness for more than 1 day following cesarean section 8 days prior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>Notable decreases were observed in platelets, hemoglobin, creatinine, and ADAMTS13 levels. After a consultative examination by an ophthalmologist, she was diagnosed with retinal hemorrhage in the right eye and dry eye syndrome in both eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Having been diagnosed with TTP with Sj\u00f6gren syndrome and renal impairment, she received repeated treatments with plasmapheresis combined with rituximab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Following treatment and during the follow-up period, the patient\u2019s platelet counts and bleeding symptoms significantly improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>TTP has a high mortality rate, and when combined with Sj\u00f6gren syndrome and renal impairment, it poses an even greater challenge in treatment. However, after administering standard plasmapheresis combined with rituximab treatment, the treatment outcome is favorable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000038103","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T14:01:54Z","timestamp":1715349714000},"page":"e38103","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Plasmapheresis combined with rituximab treatment of a case of thrombotic thrombocytopenic purpura with Sj\u00f6gren syndrome and renal impairment: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Yongqiang","family":"Zhang","sequence":"first","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Hu","sequence":"additional","affiliation":[{"name":"Guizhou Provincial People\u2019s Hospital, Guiyang 550002, Guizhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyao","family":"Deng","sequence":"additional","affiliation":[{"name":"Guizhou Provincial People\u2019s Hospital, Guiyang 550002, Guizhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8704-6762","authenticated-orcid":false,"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Guizhou Provincial People\u2019s Hospital, Guiyang 550002, Guizhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.ede.0000113273.14807.53","article-title":"Incidence of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome.","volume":"15","author":"Miller","year":"2004","journal-title":"Epidemiology"},{"key":"R2-20251125","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.","volume":"3","author":"Terrell","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R3-20251125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.19026","article-title":"A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.","volume":"203","author":"Scully","year":"2023","journal-title":"Br J Haematol"},{"key":"R4-20251125","doi-asserted-by":"crossref","first-page":"100945","DOI":"10.1016\/j.blre.2022.100945","article-title":"Advances in the management of TTP.","volume":"55","author":"Subhan","year":"2022","journal-title":"Blood Rev"},{"key":"R5-20251125","doi-asserted-by":"crossref","first-page":"e0026","DOI":"10.5041\/RMMJ.10160","article-title":"ADAMTS-13 in the diagnosis and management of thrombotic microangiopathies.","volume":"5","author":"Sarig","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"R6-20251125","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"R7-20251125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.","volume":"11","author":"Westwood","year":"2013","journal-title":"J Thromb Haemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:01:03Z","timestamp":1764072063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":7,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038103","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,5,10]]}}}